Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 109 | 115 | +6 |
| Shares | 124.1M | 133.0M | +8.86M (+7.1%) |
| Value | $3.28B | $3.76B | +$475.7M (+14.5%) |
New holders (19)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 2,001,437 | $56.6M | 0.05% |
| Finepoint Capital LP | 536,901 | $15.2M | 4.99% |
| Ikarian Capital, LLC | 178,100 | $5.03M | 2.51% |
| Alyeska Investment Group, L.P. | 87,782 | $2.48M | 0.03% |
| Casdin Capital, LLC | 80,000 | $2.26M | 0.15% |
| State of New Jersey Common Pension Fund D | 75,569 | $2.14M | 0.01% |
| Norges Bank | 73,843 | $2.09M | 0.00% |
| Squarepoint Ops LLC | 72,544 | $2.05M | 0.02% |
| BNP Paribas Arbitrage, SA | 61,985 | $1.75M | 0.00% |
| Hudson Bay Capital Management LP | 45,000 | $1.27M | 0.01% |
| Pura Vida Investments, LLC | 41,136 | $1.16M | 0.18% |
| Twinbeech Capital LP | 39,072 | $1.10M | 0.03% |
| Boothbay Fund Management, LLC | 33,959 | $960.0K | 0.03% |
| Cubist Systematic Strategies, LLC | 33,207 | $938.0K | 0.01% |
| Verition Fund Management LLC | 19,457 | $550.0K | 0.01% |
| Camden Capital, LLC | 14,500 | $410.0K | 0.10% |
| Engineers Gate Manager LP | 7,638 | $216.0K | 0.01% |
| Point72 Hong Kong Ltd | 1,470 | $42.0K | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $28.0K | 0.01% |
Sold out (13)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| EcoR1 Capital, LLC | 1,646,260 | $43.5M |
| Ally Bridge Group (NY) LLC | 170,000 | $4.50M |
| Bank of Montreal | 131,970 | $3.70M |
| Caption Management, LLC | 36,400 | $962.0K |
| Allianz Asset Management GmbH | 28,220 | $746.0K |
| Advisory Research Inc | 22,824 | $604.0K |
| Simplex Trading, LLC | 12,491 | $330.0K |
| Man Group plc | – | $321.0K |
| SG3 Management, LLC | 10,000 | $264.0K |
| Penserra Capital Management LLC | 4,652 | $122.0K |
| Group One Trading, L.P. | 3,063 | $81.0K |
| Captrust Financial Advisors | 115 | $3.00K |
| Ellevest, Inc. | 115 | $3.00K |